CD68‐IBA1 colocalization was also significantly reduced in the mPFC of both hNSC‐EV‐treated and iMGL‐EV‐treated AD mice 16 weeks post‐EV treatment (p < 0.0001). This evidence concerns the gene AIF1 and Alzheimer disease.